These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 15538074)
1. Pharmacologic update: treatment of erectile dysfunction in the elderly with phosphodiesterase type 5 inhibitors: cardiovascular implications. Agarwal P; Sander GE; Giles TD Am J Geriatr Cardiol; 2004; 13(6):332-5. PubMed ID: 15538074 [No Abstract] [Full Text] [Related]
2. New phosphodiesterase type 5 inhibitors in the management of erectile dysfunction. Mason RG J R Soc Promot Health; 2003 Jun; 123(2):79-80. PubMed ID: 12852189 [No Abstract] [Full Text] [Related]
4. Novel PDE5 inhibitors for the treatment of male erectile dysfunction. Kalsi JS; Bahadur G; Muneer A; Ozturk O; Christopher N; Ralph DJ; Minhas S Reprod Biomed Online; 2003; 7(4):456-61. PubMed ID: 14656408 [TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase 5 inhibitors in male sexual dysfunction. Kuthe A Curr Opin Urol; 2003 Sep; 13(5):405-10. PubMed ID: 12917517 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction. Kloner RA Circulation; 2004 Nov; 110(19):3149-55. PubMed ID: 15533876 [No Abstract] [Full Text] [Related]
8. Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus. Vardi M; Nini A Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD002187. PubMed ID: 17253475 [TBL] [Abstract][Full Text] [Related]
9. Are they better than Viagra? Two new drugs for erectile dysfunction work like Viagra and carry similar risks and benefits. Their subtle differences, however, may make a difference for some men. Harv Health Lett; 2004 Jan; 29(3):3. PubMed ID: 14734283 [No Abstract] [Full Text] [Related]
10. Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction. Briganti A; Salonia A; Deho' F; Zanni G; Barbieri L; Rigatti P; Montorsi F World J Urol; 2005 Dec; 23(6):374-84. PubMed ID: 16273417 [TBL] [Abstract][Full Text] [Related]
11. Editorial comment on the manuscript entitled 'Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction'. Perimenis P Expert Opin Pharmacother; 2005 Jan; 6(1):1-2. PubMed ID: 15709877 [No Abstract] [Full Text] [Related]
12. Differential effects of phosphodiesterase-5 inhibitors on hypoxic pulmonary vasoconstriction and pulmonary artery cytokine expression. Tsai BM; Turrentine MW; Sheridan BC; Wang M; Fiore AC; Brown JW; Meldrum DR Ann Thorac Surg; 2006 Jan; 81(1):272-8. PubMed ID: 16368379 [TBL] [Abstract][Full Text] [Related]
13. There have been inadequate warnings that erectile dysfunction drugs can cause blindness. Wolfe SM MedGenMed; 2005 Dec; 7(4):61. PubMed ID: 16614683 [No Abstract] [Full Text] [Related]
14. Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate. Broderick GA; Donatucci CF; Hatzichristou D; Torres LO; Valiquette L; Zhao Y; Loughney K; Sides GD; Ahuja S J Sex Med; 2006 Jul; 3(4):668-675. PubMed ID: 16839323 [TBL] [Abstract][Full Text] [Related]
15. [Birthday of a "potency pill". Helmut Newton celebrates posthumously likewise]. Keil TU MMW Fortschr Med; 2004 Jul; 146(29-30):61. PubMed ID: 15540567 [No Abstract] [Full Text] [Related]